3-formylrifamycin sv has been researched along with ethambutol in 1 studies
Studies (3-formylrifamycin sv) | Trials (3-formylrifamycin sv) | Recent Studies (post-2010) (3-formylrifamycin sv) | Studies (ethambutol) | Trials (ethambutol) | Recent Studies (post-2010) (ethambutol) |
---|---|---|---|---|---|
8 | 1 | 3 | 4,454 | 366 | 1,143 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eichelbaum, M; Jensen, JC; Loos, U; Mikus, G; Musch, E; Schwabe, HK | 1 |
1 trial(s) available for 3-formylrifamycin sv and ethambutol
Article | Year |
---|---|
Pharmacokinetics of oral and intravenous rifampicin during chronic administration.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Parenteral; Isoniazid; Male; Metabolic Clearance Rate; Middle Aged; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1985 |